Metraipolis › archive › dc_3d5c804ee91c

Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study — Europe PMC PMID:41598791

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41598791
DOI: 10.3390/jcm15020854
License (as archived): solo-consultazione
Archived: 2026-11-06T15:51:03.306Z
SHA-256 of the archived text: 2ee08a7e566ba64d2b8a761539b42654b3b8ead0472956dd2456aede464777f6
Stable URL of this page: https://metraipolis.com/documento/dc_3d5c804ee91c

How to cite

Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study — Europe PMC PMID:41598791 — Europe PMC (en), https://europepmc.org/article/MED/41598791 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_3d5c804ee91c (Metraipolis archive dc_3d5c804ee91c, sha256 2ee08a7e566ba64d2b8a761539b42654b3b8ead0472956dd2456aede464777f6)

BibTeX

@misc{dc3d5c804ee91c,
  title = {Real-World Utilization of Midostaurin in Combination with Intensive Chemotherapy for Patients with FLT3 Mutated Acute Myeloid Leukemia: A Multicenter Study — Europe PMC PMID:41598791},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41598791},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_3d5c804ee91c; sha256 2ee08a7e566ba64d2b8a761539b42654b3b8ead0472956dd2456aede464777f6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41598791. Agents can read the archived copy with the MCP tool read_document.